Maria Trojano

Risk of early relapse following the switch from injectables to oral agents for multiple sclerosis

J. Lechner-Scott, F. Grand'Maison, E. Havrdová, 2016, European journal of neurology.

Lymphocyte subsets as biomarkers of therapeutic response in Fingolimod treated Relapsing Multiple Sclerosis patients

S. Zoccolella, D. Paolicelli, P. Iaffaldano, 2017, Journal of Neuroimmunology.

Communicating the diagnosis of multiple sclerosis - a qualitative study

M. Trojano, V. Martinelli, A. Solari, 2007, Multiple sclerosis.

Quality Assurance for Cerebrospinal Fluid Protein Analysis: International Consensus by an Internet-Based Group Discussion

M. Trojano, M. Verbeek, R. Liblau, 2003, Clinical chemistry and laboratory medicine.